Influenza A(H1N1) outbreak in a long-term care facility for severely handicapped residents, Slovenia, March-April 2009

Eurosurveillance

Volumn 15, Issue 21, 2010, Pages

  Socan, M ^a   Prosenc, K ^a   Tevz Cizej N ^b  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^b Training Occupational and Care Centre   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ZANAMIVIR; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISABLED PERSON; FEMALE; FEVER; FOLLOW UP; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LONG TERM CARE; MALE; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SLOVENIA; VIRUS RESISTANCE; DRUG EFFECT; DRUG RESISTANCE; EPIDEMIC; HOSPITALIZATION; INFLUENZA; ISOLATION AND PURIFICATION; RESIDENTIAL HOME;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DISABLED PERSONS; DISEASE OUTBREAKS; DRUG RESISTANCE; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; OSELTAMIVIR; RESIDENTIAL FACILITIES; SEVERITY OF ILLNESS INDEX; SLOVENIA; YOUNG ADULT; ZANAMIVIR;

EID: 77953578873     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.21.19577-en     Document Type: Article

References (19)

1. Vaux S, Poujol I, Bonmarin I, Lévy-Bruhl D, Desenclos JC. Surveillance of lower respiratory tract infections outbreaks in nursing homes in France. Eur J Epidemiol. 2009;24(3):149-55.
2. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003-32.
3. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, et al. Oseltamivir-resistant influenza virus A(H1N1), Europe, 2007-2008 season. Emerg Infect Dis. 2009;15(4):552-60.
4. 2008/426/EC: Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2008) 1589). Available from:http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:159:0046:01:EN:HTML
5. Fouchier RA, Bestebroer TM, Herfst S, Van Der Kemp L, Rimmelzwaan GF, Osterhaus AD. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol. 2000;38(11):4096-101.
6. Ward CL, Dempsey MH, Ring CJ, Kempson RE, Zhang L, Gor D, et al. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Vir. 2004;29(3):179-88.
7. World Health Organization Regional Office for Europe (WHO EURO). European Influenza Network (EuroFlu). Fouchier RA. ELP03-2005[1], EuroFlu Protocol Library. Copenhagen: WHO EURO. [Accessed 25 May 2010]. Obtained from: http://www.euroflu.org/index.php (password protected).
8. Lackenby A, Democratis J, Siqueira MM, Zambon MC. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir Ther. 2008;13(6):809-20.
9. World Health Organization Regional Office for Europe (WHO EURO). European Influenza Network (EuroFlu). Graphs for Slovenia, season 2008/2009. Copenhagen: WHO EURO. [Accessed 25 May 2010]. Available from: http://www.euroflu.org/cgi-files/figures2002.cgi?year=2009&week=39®ion=Slovenia&type=v
10. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87(12):1944-50.
11. World Health Organization (WHO). Influenza A (H1N1) virus resistance to oseltamivir - the 2008/2009 season, northern hemisphere. Geneva: WHO; 18 March 2009. Available from: http://www.who.int/csr/disease/influenza/H1N1webupdate20090318%20ed_ns.pdf
12. Lee C, Loeb M, Phillips A, Nesbitt J, Smith K, Fearon M, et al. Zanamivir use during transmission of amantadin-resistant influenza A in a nursing home. Infect Control Hosp Epidemiol. 2000;21(11):700-4.
13. Otsuka T, Fujinaka H, Katsuyama K, Iizawa M, Kinoshita S, Tanaka Y, et al. Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season. Vaccine. 2007;25(23):4521-4.
14. Centers for Disease Control and Prevention (CDC). Guidelines and recommendations: infection control guidance for the prevention and control of influenza in acute-care facilities. Atlanta, GA: CDC; 1 July 2009. Available from: http://www.cdc.gov/flu/professionals/infectioncontrol/healthcarefacilities.htm
15. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775-85.
16. Aoki FY, Boivin G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. J Clin Virol. 2009;44(4):255-61.
17. Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol. 2007;28(9):1071-6.
18. Rubin MS, Nivin B, Ackelsberg J. Effect of timing of amantadine chemoprophylaxis on severity of outbreaks of influenza A in adult long-term care facilities. Clin Infect Dis. 2008;47(1):47-52.
19. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill. 2008;13(43). pii: 19017. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19017